Search Results 721-730 of 17144 for monoclonal antibody
Clinical Trials · Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis · More about research at ...
Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as cisplatin ...
... Antibody (ANCA) at 6 months. The study is a double ... - History of intolerance to rituximab or other chimeric monoclonal antibodies (e.g., infliximab).
composition to nivolumab (Parts A+ B) and/or ipilimumab (Part B) - History of severe hypersensitivity reaction to any monoclonal antibody - Uncontrolled ...
Prior monoclonal antibody within 4 weeks prior to study Day 1; Prior Chemotherapy, targeted small molecular therapy, or radiation therapy within 2 weeks ...
Monoclonal antibodies: at least 3 half-lives must have elapsed since prior therapy that included a monoclonal antibody; Radiation therapy (RT): >= 2 weeks ...
Adults who are just initiating monoclonal antibody therapy with pembrolizumab or nivolumab for melanoma or non-small cell lung cancer. Exclusion Criteria ...
"We included a variety of different types of cancer, including solid tumors and hematologic malignancies." Humoral response for various cancers and therapies.
Assess the effectiveness of daratumumab SC in treating patients with monoclonal immunoglobulin deposits (PGNMID) by assessing improvement in proteinuria at 12 ...
Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.